Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Gene therapy innovation should happen outside the military for ethical reasons

Peter H. Schwartz, April 2020, Indiana University Center for Bioethics, Indiana University School of Medicinehttps://www.cell.com/molecular-therapy-family/molecular-therapy/pdf/S1525-0016(20)30142-8.pdf, " Ethics of Gene Therapy in the Military: Promise and Potential Problems" Molecular Therapy Vol. 28 No 4 (ermo/sms, Acc:6-8-2022)

While certain enhancements are accepted in current medical practice, such as plastic surgery for appearance or botox for wrinkles, these cosmetic interventions are classified differently than most medical care, for instance not covered by health insurance. When proposed enhancements involve long-term medications or, worse, genetic modification, concerns grow, as can be seen with current programs in military enhancement, such as human-machine interfaces and neuroenhancement.8 The proposed gene therapy, in contrast, is more like a vaccine to protect against future illness (in this case caused by nerve agents rather than viruses).

The most important concerns about this gene therapy stem from its potential risks, much like for other new therapeutics. While being long-acting is a major point in the approach’s favor, this feature also brings potential dangers: scientists have already pointed out that the synthetic enzyme made by the gene could, by persisting in the blood stream, stimulate an immune response to the naturally occurring form, which is important in cholesterol metabolism.1 In addition, the fact that the treatment permanently modifies the individual’s genome raises the dangers of other long-term side effects, such as increasing cancer risk, which would be difficult to identify. The short-term benefits, one might hope, would make such longterm dangers acceptable, initially in research projects and then more generally in widespread use, but here things get complicated, in part because of the potential military use. For one thing, it can be difficult to carry out ethical clinical trials in the military, since military personnel may not feel as if they can choose to participate, due to command structure and culture.7,9

Perhaps even more importantly, since the treatment is preventative, it would presumably be used for all soldiers who have a significant risk of being exposed to nerve agents. But will the benefit to the potentially few soldiers who are actually exposed outweigh the risks to the many treated? Questions like this always arise for preventive interventions, such as screening tests: many people are tested and treated, but relatively few benefit. Groups such as the United States Preventive Services Task Force or American Cancer Society make recommendations by tallying up the benefits and risks at the population level.

Things are more complicated for a preventive treatment in the military, where the risk to the individual is affected by decisions by superior officers. Sending soldiers into a situation where chemical weapons may be used is slightly easier if the soldiers are at least somewhat protected. For this reason, the availability of the treatment might increase the risk to the individual soldier, on balance, by increasing the chance of their being exposed even as it reduces the harm from exposure. The treatment may thus more directly benefit military efficacy overall rather than individual soldiers.

These issues arise for all technological and medical means used to protect or treat soldiers. Think of everything from armored vehicles to the incredible advances in trauma medicine that have saved so many. All these advances are admirable and indispensable, but their availability may lead soldiers to be placed in situations with higher risk. When we start imagining making changes to soldiers’ DNA, changes that will last a lifetime, there are new, higher stakes.

Ruling on the ethics of gene therapy in the military, as for other technological advances, depends in part on judgments about how the technology or treatment will be used and for what ends. Even though the potential benefits to our soldiers and military understandably motivates this research, the first widespread uses of gene therapy may be more appropriately tested and implemented outside of the military.

Sign in to recut, update, or save this card.